Jeoung Soo Lee

Dr. Jeoung Soo Lee

Department of Bioengineering, Drug Design, Development & Delivery (4Ds) Laboratory, Clemson University, Clemson, SC 29634, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2019 in Nanomaterials
Verified
Journal Article
Open access
PDF file
BCBreanne Caffery
Breanne Caffery
Jeoung Soo LeeJeoung Soo Lee
Jeoung Soo Lee
AAAngela Alexander-Bryant
Angela Alexander-Bryant
Glioblastoma multiforme is the most common and aggressive primary brain tumor. Even with aggressive treatment including surgical resection, radiation, and chemotherapy, patient outcomes remain poor, with five-year survival rates at only 10%. Barriers to treatment include inefficient drug delivery across the blood brain barrier and development of drug resistance. Because gliomas occur due to sequential acquisition of genetic alterations, gene therapy represents a promising alternative to overcome limitations of conventional therapy. Gene or nucleic acid carriers must be used to deliver these therapies successfully into tumor tissue and have been extensively studied. Viral vectors have been evaluated in clinical trials for glioblastoma gene therapy but have not achieved FDA approval due to issues with viral delivery, inefficient tumor penetration, and limited efficacy. Non-viral vectors have been explored for delivery of glioma gene therapy and have shown promise as gene vectors for glioma treatment in preclinical studies and a few non-polymeric vectors have entered clinical trials. In this review, delivery systems including viral, non-polymeric, and polymeric vectors that have been used in glioblastoma multiforme (GBM) gene therapy are discussed. Additionally, advances in glioblastoma gene therapy using viral and non-polymeric vectors in clinical trials and emerging polymeric vectors for glioma gene therapy are discussed.

1 January 2020 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
JHJustin R. Halman
Justin R. Halman
KKKi-Taek Kim
Ki-Taek Kim
SGSo-Jung Gwak
So-Jung Gwak
RPRichard Pace
Richard Pace
MJM. Brittany Johnson
M. Brittany Johnson
KAKirill Afonin
Kirill Afonin

26 February 2021 in Biomedical Materials
Verified
Journal Article
Closed access
DJDa Un Jeong
Da Un Jeong
SBSooneon Bae
Sooneon Bae
CMChristian Macks
Christian Macks
JWJoseph Whitaker
Joseph Whitaker
MLMichael Lynn
Michael Lynn
Jeoung Soo LeeJeoung Soo Lee
Jeoung Soo Lee
Excessive and prolonged neuroinflammation leads to neuronal cell death and limits functional recovery after traumatic brain injury (TBI). Dexamethasone (DX) is a steroidal anti-inflammatory agent that is known to attenuate early expression of pro-inflammatory cytokines associated with activated microglia/macrophages. In this study, we investigated the effect of dexamethasone-conjugated hyaluronic acid (HA-DXM) incorporated in a hydrolytically degradable, photo-cross-linkable poly (ethylene) glycol-bis-(acryloyloxy acetate) (PEG-bis-AA) hydrogel on the inflammatory response, apoptosis, and functional recovery in a controlled cortical impact (CCI) rat TBI model. In vitro , DX release from PEG-bis-AA/HA-DXM hydrogel was slow in phosphate-buffered saline without enzymes, but significantly increased in the presence of hyauronidase/esterase enzymes. TBI was generated by a CCI device armed with a 3 mm tip (3.5 m s −1 , depth: 2 mm) and treated immediately with PEG-bis-AA/HA-DXM hydrogel. PEG-bis-AA/HA hydrogel without DX was used for comparison and untreated TBI group was used as a control. Significant reductions in cavity size, inflammatory response, and apoptosis were observed in animals treated with PEG-bis-AA/HA-DXM compared to those receiving PEG-bis-AA/HA and untreated. Animals receiving the PEG-bis-AA/HA-DXM hydrogel also exhibited higher neuronal cell survival and improved motor functional recovery compared to the other two groups.

1 March 2017 in Biomaterials
Verified
Journal Article
Closed access
SGSo-Jung Gwak
So-Jung Gwak
CMChristian Macks
Christian Macks
DJDa Un Jeong
Da Un Jeong
MKMark Kindy
Mark Kindy
MLMichael Lynn
Michael Lynn
Jeoung Soo LeeJeoung Soo Lee
Jeoung Soo Lee

1 February 2018 in Journal of Neurotrauma
Verified
Journal Article
Closed access
CMChristian Macks
Christian Macks
SGSo-jung Gwak
So-jung Gwak
MLMichael Lynn
Michael Lynn
Jeoung Soo LeeJeoung Soo Lee
Jeoung Soo Lee
Among the complex pathophysiological events following spinal cord injury, one of the most important molecular level consequences is a dramatic reduction in neuronal cyclic adenosine monophosphate (cAMP) levels. Many studies shown that rolipram (Rm), a phosphodiesterase IV (PDE4) inhibitor, can protect against secondary cell death, reduce inflammatory cytokine levels and immune cell infiltration, and increase white matter sparing and functional improvement. Previously, we developed a polymeric micelle nanoparticle, (poly (lactide-co-glycolide)-g-polyethylenimine, PgP) for combinatorial delivery of therapeutic nucleic acids (TNAs) and drugs for SCI repair. In this study, we evaluated PgP as a Rm delivery carrier for SCI repair. Rolipram’s water solubility was increased ~ 6.8 times in the presence of PgP, indicating drug solubilization in the micelle hydrophobic core. Using hypoxia as an in vitro SCI model, Rm-loaded PgP (Rm-PgP) restored cAMP levels and increased neuronal cell survival of cerebellar granular neurons. The potential efficacy of Rm-PgP was evaluated in a rat compression SCI model. After intraspinal injection, DiR-loaded PgP micelles were retained at the injection site for up to 5 days. Finally, we show that a single injection of Rm-PgP nanoparticles restored cAMP in the SCI lesion site and reduced apoptosis and the inflammatory response. These results suggest that PgP may offer an efficient and translational approach to delivering Rm as a neuroprotectant following SCI. Keywords: Rolipram, Polymeric micelle nanoparticle, cAMP, Secondary injury, Compression spinal cord injury

1 April 2016 in Acta Biomaterialia
Verified
Journal Article
Closed access
SGSo-Jung Gwak
So-Jung Gwak
JNJustin Nice
Justin Nice
JZJeremy Zhang
Jeremy Zhang
BGBenjamin Green
Benjamin Green
CMChristian Macks
Christian Macks
Jeoung Soo LeeJeoung Soo Lee
Jeoung Soo Lee